The Present and Future of Optic Pathway Glioma Therapy.
Dal Bello S, Martinuzzi D, Tereshko Y, Veritti D, Sarao V, Gigli GL, Lanzetta P, Valente M.
Cells. 2023 Sep 29;12(19):2380. doi: 10.3390/cells12192380.
Optic pathway glioma of childhood.
Rasool N, Odel JG, Kazim M.
Curr Opin Ophthalmol. 2017 May;28(3):289-295. doi: 10.1097/ICU.0000000000000370.
NF1 mutation drives neuronal activity-dependent initiation of optic glioma.
Pan Y, Hysinger JD, Barron T, Schindler NF, Cobb O, Guo X, Yalçın B, Anastasaki C, Mulinyawe SB, Ponnuswami A, Scheaffer S, Ma Y, Chang KC, Xia X, Toonen JA, Lennon JJ, Gibson EM, Huguenard JR, Liau LM, Goldberg JL, Monje M, Gutmann DH.
Nature. 2021 Jun;594(7862):277-282. doi: 10.1038/s41586-021-03580-6. Epub 2021 May 26.
Optic nerve glioma: an update.
Nair AG, Pathak RS, Iyer VR, Gandhi RA.
Int Ophthalmol. 2014 Aug;34(4):999-1005. doi: 10.1007/s10792-014-9942-8. Epub 2014 Apr 16.
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.
Fangusaro J, Onar-Thomas A, Poussaint TY, Wu S, Ligon AH, Lindeman N, Campagne O, Banerjee A, Gururangan S, Kilburn LB, Goldman S, Qaddoumi I, Baxter P, Vezina G, Bregman C, Patay Z, Jones JY, Stewart CF, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M.
Neuro Oncol. 2021 Oct 1;23(10):1777-1788. doi: 10.1093/neuonc/noab047.
Current treatment of optic nerve gliomas.
Farazdaghi MK, Katowitz WR, Avery RA.
Curr Opin Ophthalmol. 2019 Sep;30(5):356-363. doi: 10.1097/ICU.0000000000000587.
An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies.
Chen Y, Yu J, Ge S, Jia R, Song X, Wang Y, Fan X.
Invest Ophthalmol Vis Sci. 2024 Jun 3;65(6):8. doi: 10.1167/iovs.65.6.8.
Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
Freret ME, Gutmann DH.
J Neurosci Res. 2019 Jan;97(1):45-56. doi: 10.1002/jnr.24250. Epub 2018 Apr 28.
Optic nerve glioma.
Cirak B.
J Neurosurg. 2003 Sep;99(2 Suppl):246; author reply 246. doi: 10.3171/spi.2003.99.2.0246.
Hypofractionated stereotactic irradiation for optic nerve glioma.
Zagirov RI, Trunin YY, Serova NK, Pronin IN, Antipina NA, Golanov AV.
Zh Vopr Neirokhir Im N N Burdenko. 2022;86(5):74-80. doi: 10.17116/neiro20228605174.
